Simon J de Veer

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Structural Basis

Vascular Smooth Muscle Cells

Top Venues

Angewandte Chemie (International ed. in English)

ACS infectious diseases

Journal of medicinal chemistry

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Nicole Lawrence, Thomas N G Handley, Simon J de Veer, Maxim D Harding, Alicja Andraszek, Lachlan Hall, Karoline D Raven, Sandra Duffy, Vicky M Avery, David J Craik, Lara R Malins, Brendan J McMorran
Enhancing the Intrinsic Antiplasmodial Activity and Improving the Stability and Selectivity of a Tunable Peptide Scaffold Derived from Human Platelet Factor 4. ACS infectious diseases 10 (8) (2024)
Simon J de Veer, Yan Zhou, Thomas Durek, David J Craik, Fabian B H Rehm
Tertiary amide bond formation by an engineered asparaginyl ligase. Chemical science 15 (14) (2024)
Nicole Lawrence, Thomas N G Handley, Simon J de Veer, Maxim D Harding, Alicja Andraszek, Lachlan Hall, Karoline D Raven, Sandra Duffy, Vicky M Avery, David J Craik, Lara R Malins, Brendan J McMorran
Enhancing the Intrinsic Antiplasmodial Activity and Improving the Stability and Selectivity of a Tunable Peptide Scaffold Derived from Human Platelet Factor 4. ACS infectious diseases (2024)
Simon J de Veer, Yan Zhou, Thomas Durek, David J Craik, Fabian B H Rehm
Tertiary amide bond formation by an engineered asparaginyl ligase. Chemical science 15 (14) (2024)
Nicole Lawrence, Thomas N G Handley, Simon J de Veer, Maxim D Harding, Alicja Andraszek, Lachlan Hall, Karoline D Raven, Sandra Duffy, Vicky M Avery, David J Craik, Lara R Malins, Brendan J McMorran
Enhancing the Intrinsic Antiplasmodial Activity and Improving the Stability and Selectivity of a Tunable Peptide Scaffold Derived from Human Platelet Factor 4. ACS infectious diseases 10 (8) (2024)
Nicole Lawrence, Thomas N G Handley, Simon J de Veer, Maxim D Harding, Alicja Andraszek, Lachlan Hall, Karoline D Raven, Sandra Duffy, Vicky M Avery, David J Craik, Lara R Malins, Brendan J McMorran
Enhancing the Intrinsic Antiplasmodial Activity and Improving the Stability and Selectivity of a Tunable Peptide Scaffold Derived from Human Platelet Factor 4. ACS infectious diseases 10 (8) (2024)
Fabian B H Rehm, Tristan J Tyler, Simon J de Veer, David J Craik, Thomas Durek
Enzymatic C-to-C Protein Ligation. Angewandte Chemie (International ed. in English) 61 (11) (2022)
Choi Yi Li, Fabian B H Rehm, Kuok Yap, Christina N Zdenek, Maxim D Harding, Bryan G Fry, Thomas Durek, David J Craik, Simon J de Veer
Cystine Knot Peptides with Tuneable Activity and Mechanism. Angewandte Chemie (International ed. in English) 61 (19) (2022)
Yue Wu, Zhenling Cui, Yen-Hua Huang, Simon J de Veer, Mikhail S Baranov, Zhong Guo, Shayli V Moradi, Alexandra O Hinton, Jennifer R Deuis, Shaodong Guo, Kai-En Chen, Brett M Collins, Irina Vetter, Volker Herzig, Alun Jones, Matthew A Cooper, Glenn F King, David J Craik, Kirill Alexandrov, Sergey Mureev
Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation system. Nature communications 13 (1) (2022)
Sixin Tian, Thomas Durek, Conan K Wang, Christina N Zdenek, Bryan G Fry, David J Craik, Simon J de Veer
Engineering the Cyclization Loop of MCoTI-II Generates Targeted Cyclotides that Potently Inhibit Factor XIIa. Journal of medicinal chemistry 65 (23) (2022)
Thomas Durek, Quentin Kaas, Andrew M White, Joachim Weidmann, Abdullah Ahmad Fuaad, Olivier Cheneval, Christina I Schroeder, Simon J de Veer, Anita Dellsén, Torben Österlund, Niklas Larsson, Laurent Knerr, Udo Bauer, Alleyn T Plowright, David J Craik
Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework. Journal of medicinal chemistry 64 (14) (2021)
Wenyu Liu, Simon J de Veer, Yen-Hua Huang, Toru Sengoku, Chikako Okada, Kazuhiro Ogata, Christina N Zdenek, Bryan G Fry, Joakim E Swedberg, Toby Passioura, David J Craik, Hiroaki Suga
An Ultrapotent and Selective Cyclic Peptide Inhibitor of Human β-Factor XIIa in a Cyclotide Scaffold. Journal of the American Chemical Society 143 (44) (2021)
Kuok Yap, Junqiao Du, Fabian B H Rehm, Shyn Ric Tang, Yan Zhou, Jing Xie, Conan K Wang, Simon J de Veer, Linda H L Lua, Thomas Durek, David J Craik
Yeast-based bioproduction of disulfide-rich peptides and their cyclization via asparaginyl endopeptidases. Nature protocols 16 (3) (2021)
Fabian B H Rehm, Tristan J Tyler, Kuok Yap, Simon J de Veer, David J Craik, Thomas Durek
Enzymatic C-Terminal Protein Engineering with Amines. Journal of the American Chemical Society 143 (46) (2021)
Andrew M White, Simon J de Veer, Guojie Wu, Peta J Harvey, Kuok Yap, Gordon J King, Joakim E Swedberg, Conan K Wang, Ruby H P Law, Thomas Durek, David J Craik
Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides. Angewandte Chemie (International ed. in English) 59 (28) (2020)
Choi Yi Li, Kuok Yap, Joakim E Swedberg, David J Craik, Simon J de Veer
Binding Loop Substitutions in the Cyclic Peptide SFTI-1 Generate Potent and Selective Chymase Inhibitors. Journal of medicinal chemistry 63 (2) (2020)
Simon J de Veer, Andrew M White, David J Craik
Sunflower Trypsin Inhibitor-1 (SFTI-1): Sowing Seeds in the Fields of Chemistry and Biology. Angewandte Chemie (International ed. in English) 60 (15) (2020)
Simon J de Veer, Meng-Wei Kan, David J Craik
Cyclotides: From Structure to Function. Chemical reviews 119 (24) (2019)
Blake T Riley, Olga Ilyichova, Simon J de Veer, Joakim E Swedberg, Emily Wilson, David E Hoke, Jonathan M Harris, Ashley M Buckle
KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors. Biochemistry 58 (21) (2019)
Choi Yi Li, Simon J de Veer, Andrew M White, Xingchen Chen, Jonathan M Harris, Joakim E Swedberg, David J Craik
Amino Acid Scanning at P5' within the Bowman-Birk Inhibitory Loop Reveals Specificity Trends for Diverse Serine Proteases. Journal of medicinal chemistry 62 (7) (2019)